Literature DB >> 18642467

Age for HPV vaccination.

Diane M Harper1, Jorma Paavonen.   

Abstract

HPV vaccination of pre-pubescent girls will be effective for many girls. Vaccinating girls and women older than 12 years of age may accelerate the reduction in cervical cancer rates. Currently HPV vaccines are effective for at least 5 years in the prevention of HPV 16 and 18 associated precancerous lesions however the duration of vaccine protection is unknown. The need for booster shots must therefore be addressed with patients as unknown. Continued cervical cancer screening is necessary regardless of vaccination. Vaccination alone will not eliminate cervical cancer.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18642467     DOI： 10.1016/j.vaccine.2008.01.013

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  6 in total

1.  Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study.

Authors:  Andrew F Brouwer; Lora P Campredon; Heather M Walline; Brittany M Marinelli; Christine M Goudsmit; Trey B Thomas; Rachel L Delinger; Yan Kwan Lau; Emily C Andrus; Monica L Yost; Jodi K McCloskey; Taylor S Sullivan; Alex S Mortensen; Suiyuan Huang; Keith Murphy; Bonnie Cheng; Kayla Stanek; Thankam Nair; Thomas E Carey; Rafael Meza; Marisa C Eisenberg
Journal:  PLoS One       Date:  2022-05-16       Impact factor: 3.752

Review 2.  Factors influencing familial decision-making regarding human papillomavirus vaccination.

Authors:  Heather L Gamble; James L Klosky; Gilbert R Parra; Mary E Randolph
Journal:  J Pediatr Psychol       Date:  2009-12-04

3.  Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females.

Authors:  Diane M Harper; Stephen L Vierthaler
Journal:  ISRN Obstet Gynecol       Date:  2011-11-02

Review 4.  Cross sectional study investigating the differences in knowledge and behaviors about HPV between vaccinated and non-vaccinated girls.

Authors:  M R Gualano; M Stillo; M V Mussa; C M Zotti
Journal:  J Prev Med Hyg       Date:  2016-09

5.  Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland.

Authors:  Themba G Ginindza; Benn Sartorius; Xolisile Dlamini; Ellinor Östensson
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

6.  Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study.

Authors:  Deborah Watson-Jones; Keith Tomlin; Pieter Remes; Kathy Baisley; Riziki Ponsiano; Selephina Soteli; Silvia de Sanjosé; John Changalucha; Saidi Kapiga; Richard J Hayes
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.